Company: VREOF
Filing Date: 2025-05-09
Form Type: DEF 14A
Source: 0001140361-25-018064
Chunk: 42

Company: Vireo Growth Inc.
Filing Date: 2025-05-09
Form: DEF 14A
Chunk 42
---
che vesting on December 31, 2026. |

| (3) | RSUs that settle on the third anniversary of the grant date December 14, 2022. |

| (4) | RSUs that 50% vest on December 17, 2025, and vest in 12.5% installments every quarter thereafter until fully vested on December 17, 2026. Once vested, these RSUs only settle upon separation from service |

| (5) | Options that fully vest on August 22, 2025. |

| (6) | Options that vest in 25% installments on the anniversary of the grant date until fully vested on August 23, 2028. |

| (7) | 25% of these Company Options vest on December 31, 2024, and the remainder will vest ratably on the last day of each calendar quarter until fully vested on December 31, 2027. |

| (8) | 50% of these Options vest on October 10, 2025, and the remainder will vest on October 10, 2026. |

| (9) | Options vest quarterly in equal amounts, with the final tranche vesting on December 31, 2027. |

| (10) | RSUs that settle on the third anniversary of the grant date March 15, 2022. |

| (11) | RSUs that settled on February 3, 2025. |

Retirement Benefit Plans The Company did not offer any retirement benefit plans to executives in 2024. Termination and Change in Control Benefits As described in more detail above, the Company entered into employment agreements with Mr. Mazarakis, Ms. Shimpa, Dr. Kingsley and Mr. Macdonald. The following describes the benefits to which each of these NEOs is entitled under his or her employment agreement upon certain events. Under their respective agreements, none of the NEOs is eligible for any post-termination benefits in the event of termination for Cause (as defined below) or without Good Reason (as defined below). John Mazarakis If Mr. Mazarakis’ employment with the Company is terminated during the term of his employment agreement by the Company without Cause or by Mr. Mazarakis for Good Reason, then the Company will, in addition to paying Mr. Mazarakis’ base salary and other compensation earned through the termination date, (a) pay an amount equal to